EUDA Health Holdings Limited
NASDAQ:EUDA
3.41 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.107 | 1.699 | 2.434 | 2.311 | 2.428 | 2.667 | 2.693 | 2.694 | 2.516 | 2.642 |
| Cost of Revenue
| 0.809 | 1.295 | 1.617 | 1.707 | 1.768 | 1.396 | 1.58 | 1.698 | 1.515 | 1.507 |
| Gross Profit
| 0.298 | 0.404 | 0.818 | 0.605 | 0.661 | 1.271 | 1.113 | 0.995 | 1.002 | 1.135 |
| Gross Profit Ratio
| 0.269 | 0.238 | 0.336 | 0.262 | 0.272 | 0.477 | 0.413 | 0.369 | 0.398 | 0.429 |
| Reseach & Development Expenses
| 0.017 | 0.003 | 0.002 | 0.005 | 0.007 | 0.003 | 0.051 | 0 | 0.037 | 0.042 |
| General & Administrative Expenses
| 2.088 | 1.976 | 3.349 | 0.832 | 2.106 | 0.825 | 0.922 | 0.987 | 0.993 | 0.976 |
| Selling & Marketing Expenses
| 0.126 | 0.405 | 0.758 | 0.494 | 0.283 | 0.368 | 0.298 | 0.294 | 0.323 | 0.343 |
| SG&A
| 2.215 | 2.38 | 4.149 | 1.326 | 1.233 | 0.482 | 0.226 | 0.046 | 0.001 | 0.008 |
| Other Expenses
| 0.018 | -0.424 | 7.029 | -0.035 | -0.021 | 0.146 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 2.231 | 2.38 | 23.363 | 1.331 | 1.233 | 0.482 | 0.226 | 0.046 | 0.001 | 0.008 |
| Operating Income
| -2.058 | -1.977 | -8.533 | -0.726 | -1.233 | -0.482 | -0.226 | -0.046 | -0.001 | -0.008 |
| Operating Income Ratio
| -1.859 | -1.164 | -3.505 | -0.314 | -0.508 | -0.181 | -0.084 | -0.017 | -0 | -0.003 |
| Total Other Income Expenses Net
| -4.159 | -0.424 | -14.097 | -0.039 | 0.214 | 0.009 | 0.001 | 0 | 0 | 0 |
| Income Before Tax
| -6.1 | -2.412 | -22.629 | -0.765 | -1.019 | -0.473 | -0.225 | -0.046 | -0.001 | -0.008 |
| Income Before Tax Ratio
| -5.51 | -1.42 | -9.296 | -0.331 | -0.42 | -0.177 | -0.084 | -0.017 | -0 | -0.003 |
| Income Tax Expense
| -0 | 0.001 | 0.057 | -0.023 | 0.092 | 0.006 | 0.002 | 0.003 | 0.04 | 0.013 |
| Net Income
| -6.1 | -2.415 | -22.506 | -0.741 | -1.019 | -0.473 | -0.225 | -0.046 | -0.001 | -0.008 |
| Net Income Ratio
| -5.51 | -1.421 | -9.245 | -0.321 | -0.42 | -0.177 | -0.084 | -0.017 | -0 | -0.003 |
| EPS
| -0.28 | -0.12 | -0.5 | -0.067 | -0.092 | -0.043 | -0.021 | -0.005 | -0 | -0.001 |
| EPS Diluted
| -0.28 | -0.12 | -0.5 | -0.067 | -0.092 | -0.043 | -0.021 | -0.005 | -0 | -0.001 |
| EBITDA
| -1.915 | -2.358 | -8.489 | -0.696 | -1.233 | -0.482 | -0.226 | -0.046 | -0.001 | -0.008 |
| EBITDA Ratio
| -1.73 | -1.388 | -3.487 | -0.301 | -0.508 | -0.181 | -0.084 | -0.017 | -0 | -0.003 |